60
Participants
Start Date
July 8, 2014
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2032
Temozolomide
Patients will be scheduled to receive continuous daily temozolomide (75 mg per square meter of body surface area per day, 7 days per week from the first to the last day of radiation therapy), followed by 6 cycles of adjuvant temozolomide (150 to 200 mg per square meter for 5 days during each 28 day cycle).
Subventricular Zone radiation
"Patients will receive 60 Gy in 30 fractions, 5 days per week using IMRT. The target delineation and treatment volumes will be as follows:~Initial treatment plan:~Will be prescribed to 46 Gy in 2 Gy fractions~Cone down treatment plan:~Will be prescribed to 14 Gy in 2 Gy fractions"
Neural Progenitor Cell Sparing radiation
"Patients will receive 60 Gy in 30 fractions, 5 days per week using IMRT. The target delineation and treatment volumes will be as follows:~Initial treatment plan:~Will be prescribed to 46 Gy in 2 Gy fractions~Cone down treatment plan:~Will be prescribed to 14 Gy in 2 Gy fractions"
RECRUITING
The SKCCC at Johns Hopkins, Baltimore
RECRUITING
Sibley Memorial Hospital, Washington D.C.
RECRUITING
Suburban Hospital, Bethesda
Reading Health System Foundation
UNKNOWN
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER